Welcome to the European Association for Cancer Research
Connecting cancer researchers together
EACR-AstraZeneca Cancer Epigenetics
Virtual Event, Worldwide : 5 - 6 December 2023
Scientific Programme
To download and print the programme, use the links below.
Listed times are in Central European Time (CET)
WELCOME TO DAY ONE
Kristian Helin and Ho Man Chan
TARGETING EPIGENETICS IN CANCER: SESSION 1
Chair: Mark Dawson
Ricky Johnstone Peter MacCallum Cancer Centre, Victoria, Australia
'Targeting transcriptional CDKs in cancer'
Q&A 13:30 - 13:45
Celine Vallot Institut Curie, Paris, France
'Epigenetic targeting of chemoresistance in cancer'
Q&A 14:05 - 14:20
Refreshment Break
Chair: Ho Man Chan
Eytan Stein MSKCC, New York, USA
'Novel epigenetic therapies for acute myeloid leukemia'
Q&A 14:55 - 15:10
Naiara Perurena Aizcorbe Brigham and Women's Hospital, Boston, USA
Proffered Paper 2: 'EZH2 Inhibitors Create a Dependency on YAP for Survival in HER2+ Breast Cancers'
Q&A 15:20 - 15:30
Refreshment break
Kathrin Bernt Children's Hospital of Philadelphia, Philadelphia, USA
'Intrinsically disordered domains and transcription control in cancer'
Chair: Jingwen Zhang
Q&A 16:10 - 16:25
POSTER SPOTLIGHTS
Chair: Jingwen Zhang
Daniel Angelov, Trinity College Dublin, Dublin, Ireland; Buse Cevatemre, Koç University, Istanbul, Turkey; María Rodrigo-Faus, Universidad Complutense de Madrid, Madrid, Spain
END OF DAY 1 WEBINAR
VIRTUAL POSTER DISCUSSION SESSION 1
Listed times are in Central European Time (CET)
VIRTUAL POSTER DISCUSSION SESSION 2
WELCOME TO DAY TWO
Kristian Helin and Ho Man Chan
TARGETING EPIGENETICS IN CANCER: SESSION 2
Chair: Mark Dawson
Oliver Raush Storm Therapeutics Ltd, Cambridge, UK
'Small molecule inhibition of the RNA methyltransferase METTL3 activates anti-tumour immune responses'
Q&A 14:25 - 14:40
Cintia Checa Rodriguez Institute of biomedicine of Sevilla (IBIS), Sevilla, Spain
Proffered Paper 3: 'RNAPII-facilitated repair of ribosomal DNA breaks in nucleolar caps guards against genomic instability'
Q&A 14:50 - 15:00
Refreshment Break
Chair: Jingwen Zhang
Leslie Duplaquet Dana Farber Cancer Institute, Boston, USA
Proffered Paper 4: 'KDM6A epigenetically regulates subtype plasticity in small cell lung cancer'
Q&A 15:25 - 15:35
Cigall Kadoch Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA
'Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Human Cancer'
Q&A 15:55 - 16:10
Refreshment Break
Chair: Cigall Kadoch
Ernesto Guccione EG Lab, Mount Sinai, New York, USA
'Precision medicine in solid tumors'
Q&A 16:45 - 17:00
Sangeeta Goswami MD Anderson Cancer Center, Houston, USA
'Targeting Epigenetic Pathways to Improve Response to Immune Checkpoint Therapy'
Q&A 17:20 - 17:35
DISCUSSION SESSION
'How to use Epigenetic Therapies in Cancer' and 'What epigenomic features need to be routinely measured in clinical protocol? Has this been done already? If not, why not?'
This will be an open forum with SPC members and speakers, Kristian, Ho Man, Eytan, Sangeeta and Celine
SUMMARY AND CLOSE
Kristian Helin and Ho Man Chan
Key dates
Abstract submission deadline:
09 October 2023
Registration deadline:
13 November 2023
